United Capital Financial Advisers LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 4.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 141,556 shares of the medical equipment provider’s stock after buying an additional 6,049 shares during the quarter. United Capital Financial Advisers LLC’s holdings in Intuitive Surgical were worth $42,704,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. LMR Partners LLP bought a new position in Intuitive Surgical in the fourth quarter worth approximately $636,000. Mitchell Mcleod Pugh & Williams Inc. raised its holdings in Intuitive Surgical by 7.9% in the 1st quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 679 shares of the medical equipment provider’s stock worth $205,000 after purchasing an additional 50 shares during the period. Envestnet Asset Management Inc. lifted its position in Intuitive Surgical by 0.9% during the first quarter. Envestnet Asset Management Inc. now owns 440,904 shares of the medical equipment provider’s stock valued at $133,012,000 after purchasing an additional 3,982 shares in the last quarter. MCIA Inc grew its holdings in Intuitive Surgical by 5.6% during the first quarter. MCIA Inc now owns 3,596 shares of the medical equipment provider’s stock valued at $1,003,000 after purchasing an additional 190 shares during the period. Finally, Raymond James Financial Services Advisors Inc. grew its holdings in Intuitive Surgical by 0.7% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 88,814 shares of the medical equipment provider’s stock valued at $26,793,000 after purchasing an additional 578 shares during the period. 82.44% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
ISRG has been the topic of a number of analyst reports. Truist Financial lowered their price objective on Intuitive Surgical from $270.00 to $255.00 and set a “buy” rating on the stock in a research report on Friday, July 22nd. TheStreet downgraded shares of Intuitive Surgical from a “b-” rating to a “c+” rating in a report on Thursday, May 19th. Morgan Stanley reduced their price objective on shares of Intuitive Surgical from $300.00 to $225.00 and set an “equal weight” rating for the company in a research note on Friday, July 15th. Citigroup decreased their price objective on shares of Intuitive Surgical from $360.00 to $305.00 in a research report on Tuesday, May 17th. Finally, Piper Sandler upped their target price on shares of Intuitive Surgical from $255.00 to $260.00 and gave the stock an “overweight” rating in a report on Thursday, August 18th. Six analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $268.00.
Insiders Place Their Bets
Intuitive Surgical Price Performance
NASDAQ ISRG opened at $221.32 on Friday. Intuitive Surgical, Inc. has a 1-year low of $186.83 and a 1-year high of $369.69. The business has a 50 day simple moving average of $219.35 and a two-hundred day simple moving average of $238.92. The stock has a market capitalization of $79.04 billion, a PE ratio of 56.32, a P/E/G ratio of 6.16 and a beta of 1.31.
Intuitive Surgical (NASDAQ:ISRG – Get Rating) last posted its earnings results on Thursday, July 21st. The medical equipment provider reported $1.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.01 by $0.13. Intuitive Surgical had a net margin of 24.05% and a return on equity of 12.04%. During the same period last year, the firm earned $1.42 earnings per share. On average, analysts anticipate that Intuitive Surgical, Inc. will post 3.76 EPS for the current fiscal year.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.